CA2 - carbonic anhydrase 2 Gene

Also Known as CAC; CAII; Car2; CA-II; HEL-76; HEL-S-282

Species: Homo sapiens

Gene Type: protein coding

Gene ID: 760

About CA2

Cytogenetic location: 8q21.2 Genomic coordinates (GRCh38): 8:85,464,007-85,481,493 (from NCBI)

This gene has 5 transcripts (splice variants), 285 orthologues, 14 paralogues and is associated with 3 phenotypes. Biased expression in stomach (RPKM 493.8), colon (RPKM 349.1) and 8 other tissues.

Summary

The protein encoded by this gene is one of several isozymes of Carbonic Anhydrase, which catalyzes reversible hydration of carbon dioxide. Defects in this enzyme are associated with osteopetrosis and renal tubular acidosis. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2014]

CA2 Products (2)

mRNA	Protein	Name
NM_001293675.2	NP_001280604.1	carbonic anhydrase 2 isoform 2
NM_000067.3	NP_000058.1	carbonic anhydrase 2 isoform 1

Gene Ontology

Molecular Function
Biological Process
Cellular Component

Molecular Function GO Annotation	Evidence	References	Source
enables arylesterase activity	IMP IMP: Inferred from mutant phenotype	3126084	GOA
enables carbonate dehydratase activity	IMP IMP: Inferred from mutant phenotype	1336460	GOA
enables protein binding	IPI IPI: Inferred from physical interaction	14736710	GOA
enables zinc ion binding	IDA IDA: Inferred from direct assay	3151020	GOA

Biological Process GO Annotation	Evidence	References	Source
involved in angiotensin-activated signaling pathway	IDA IDA: Inferred from direct assay	15990874	GOA
involved in regulation of monoatomic anion transport	IDA IDA: Inferred from direct assay	15990874	GOA

Cellular Component GO Annotation	Evidence	References	Source
located in apical part of cell	IDA IDA: Inferred from direct assay	14675051	GOA
located in cytoplasm	IDA IDA: Inferred from direct assay	114507	GOA
located in plasma membrane	IDA IDA: Inferred from direct assay	15990874	GOA

EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern

CA2 Protein Structure

Carb_anhydrase

0
100
200
260 a.a.

Protein Preferred Names	Protein Names
carbonic anhydrase 2	carbonate dehydratase II carbonic anhydrase B carbonic anhydrase C carbonic anhydrase II carbonic dehydratase cyanamide hydratase CA2 epididymis luminal protein 76 epididymis secretory protein Li 282

Recombinant CA2 Proteins

Cat. No.	Product Name	Accession	Purity
HY-P78746	Carbonic Anhydrase 2 Protein, Human (HEK293, His)	NP_000058.1 (M1-K260)	≥ 95%, as determined by reducing SDS-PAGE.

CA2 Antibodies

Cat. No.	Product Name	Application	Reactivity
HY-P83617	Carbonic Anhydrase 2 Antibody (YA3362)	WB, IHC-P	Human, Mouse, Rat
HY-P83617A	Carbonic Anhydrase 2 Antibody (YA3362)(PBS only)	WB, IHC-P	Human, Mouse, Rat

Related Diseases

Diseases	Alias
Distal Renal Tubular Acidosis	Classic Rta Familial Distal Primary Acidosis Renal Tubular Acidosis Type 1 Drta Renal Tubular Acidosis, Distal
Osteopetrosis, Autosomal Recessive 3	Osteopetrosis With Renal Tubular Acidosis Marble Brain Disease OPTB3 Guibaud-Vainsel Syndrome Carbonic Anhydrase Ii Deficiency Osteopetrosis, Autosomal Recessive 3, With Renal Tubular Acidosis Autosomal Recessive Osteopetrosis 3 Carbonic Anhydrase 2 Deficiency Autosomal Recessive Osteopetrosis 3 With Renal Tubular Acidosis Osteopetrosis Autosomal Recessive 3 Autosomal Recessive Osteopetrosis Type 3 Guibaud Vainsel Syndrome Mixed Rta Mixed Renal Tubular Acidosis Renal Tubular Acidosis Type 3 Carbonic Anhydrase Ii Deficiency Syndrome Carbonic Anhydrase Ii Variant Osteopetrosis, Autosomal Recessive, Type 3 Carbonic Anhydrase 2
Autoimmune Hepatitis	Aih Hepatitis, Autoimmune Autoimmune Chronic Active Hepatitis Autoimmune Hepatitis With Centrilobular Necrosis Autoimmune Chronic Hepatitis Hepatitis Autoimmune
Corneal Dystrophy, Band-Shaped	Band Keratopathy Band-Shaped Keratopathy
Primary Biliary Cholangitis	Primary Biliary Cirrhosis Biliary Liver Cirrhosis Chronic Nonsuppurative Destructive Cholangitis Familial Primary Biliary Cirrhosis Pbc Hanot Syndrome Cholestatic Cirrhosis Biliary Cirrhosis Primary Liver Cirrhosis, Biliary Hanot'S Cirrhosis Biliary Cirrhosis Pericholangiolic Biliary Cirrhosis Tannhauser-Magendantz Syndrome Hanot-Rossle Syndrome Hypertrophic Cirrhosis Todd Cirrhosis Hanot Cirrhosis Charcot Cirrhosis Mahon-Tannhauser Syndrome Toxic Cirrhosis Hypertrophic Biliary Cirrhosis Monolobular Cirrhosis Unilobar Cirrhosis Xanthomatous Biliary Cirrhosis
Pancreatitis	Mumps Pancreatitis
Sjogren Syndrome	Sicca Syndrome Sjogren'S Syndrome Sjogren-Gougerot Syndrome Sjögren Syndrome Keratoconjunctivitis Sicca Sjögren'S Syndrome Xerodermosteosis Dacryosialoadenopathia Atrophicans Gougerot-Houwer-Sjogren Syndrome Gougerot-Sjogren Syndrome Keratoconjunctivitis Sicca-Xerostomia Secreto-Inhibitor-Xerodermostenosis Primary Sjogren Syndrome Primary Sjogren-Gougerot Syndrome Sjogrens Syndrome Primary Sjogrens Syndrome Dry Eye Syndromes
Cholangitis	Acute Cholangiolitis Ascending Cholangitis Cholangiolitis Cholangitis Nos Chronic Cholangiolitis Hepatic Duct Inflammation Acute Cholangitis Bile Duct Inflammation
Multiple Cranial Nerve Palsy	Multiple Cranial Nerve Palsies
Benign Giant Cell Tumor	Giant Cell Tumors
Eye Disease	Eye Diseases Abnormality Of The Eye Toxoplasma Oculopathy
Osteopetrosis, Autosomal Dominant 2	OPTA2 Autosomal Dominant Osteopetrosis 2 Osteopetrosis Autosomal Dominant Type 2 Osteopetrosis, Autosomal Dominant, Type Ii Albers-Schonberg Osteopetrosis Autosomal Dominant Albers-Schonberg Disease Osteopetrosis Marble Bones, Autosomal Dominant Osteosclerosis Fragilis Generalisata Albers-Schonberg Disease, Autosomal Dominant Autosomal Dominant Osteopetrosis Type Ii Albers-Schönberg Osteopetrosis Autosomal Dominant Osteopetrosis Type 2 Marble Disease Autosomal Dominant Osteopetrosis, Autosomal Dominant, Type 2
Deficiency Anemia	Anemia Deficiency Anemias Anaemia
Glossopharyngeal Nerve Disease	Ninth Cranial Nerve Disease Glossopharyngeal Nerve Diseases Disorders Of The Ninth Cranial Nerve Disorders Of 9th Cranial Nerve
Pancreatic Cancer	Pancreatic Carcinoma Familial Pancreatic Carcinoma Pancreatic Neoplasm Carcinoma Of Pancreas Pancreatic Carcinoma, Familial Malignant Neoplasm Of Pancreas Pancreatic Acinar Carcinoma Pancreatic Tumor Familial Pancreatic Cancer Neoplasm Of The Pancreas Pancreatic Carcinoma, Somatic Pancreatic Cancer, Somatic Ca Body Of Pancreas Ca Head Of Pancreas Ca Tail Of Pancreas Malignant Neoplasm Of Body Of Pancreas Malignant Neoplasm Of Head Of Pancreas Malignant Neoplasm Of Tail Of Pancreas Pancreas Neoplasm Exocrine Cancer Exocrine Pancreas Carcinoma Hereditary Pancreatic Cancer Hereditary Pancreatic Carcinoma PNCA Cancer Of The Pancreas Pancreatic Cancer, Susceptibility To Carcinoma Of Head Of Pancreas Pancreatic Neoplasms Pancreatic Tumors Cancer, Pancreatic Cancer Of Pancreas Mixed Islet Cell With Exocrine Carcinoma Of Unspecified Site
Endosteal Hyperostosis, Autosomal Dominant	Osteosclerosis Worth Syndrome Osteosclerosis, Autosomal Dominant Hyperostosis, Endosteal Endosteal Hyperostosis, Worth Type Worth Disease Autosomal Dominant Osteosclerosis, Worth Type Hyperostosis Corticalis Generalisata, Benign Form Of Worth, With Torus Palatinus Autosomal Dominant Endosteal Hyperostosis Autosomal Dominant Osteosclerosis Benign Form Of Worth Hyperostosis Corticalis Generalisata With Torus Platinus Worth'S Syndrome Worth Type Autosomal Dominant Osteosclerosis Hyperostosis Corticalis Generalisata, Benign Form Of Worth With Torus Palatinus Osteosclerosis, Autosomal Dominant, Worth Type WENHY Endosteal Hyperostosis Autosomal Dominant Hyperostosis Corticalis Generalisata Benign Form Of Worth With Torus Palatinus Osteosclerosis Autosomal Dominant Acquired Osteosclerosis
Retinitis Pigmentosa	RP Rod-Cone Dystrophy Autosomal Recessive Retinitis Pigmentosa Non-Syndromic Retinitis Pigmentosa Pericentral Pigmentary Retinopathy Pigmentary Retinopathy Tapetoretinal Degeneration Rcd Retinitis Pigmentosa Autosomal Recessive ARRP Retinitis Pigmentosa, Autosomal Recessive Retinitis Pigmentosa 1
Intracranial Hypertension, Idiopathic	Pseudotumor Cerebri Benign Intracranial Hypertension Idiopathic Intracranial Hypertension Iih Benign Intracran. Hypt.
Hereditary Elliptocytosis	Congenital Elliptocytosis Ovalocytosis Elliptocytosis, Hereditary He Elliptocytosis Hereditary Congenital Ovalocytosis Elliptocytosis Hereditary Elliptocytosis With Infantile Poikilocytosis Hereditary Ovalocytosis Oval Erythrocytosis He - [Hereditary Elliptocytosis] Elliptocytosis Anaemia
Ocular Hypertension	Hypertension, Ocular Intraocular Pressure Increase Oh - [Ocular Hypertension] Oht - [Ocular Hypertension]
Intraocular Pressure Quantitative Trait Locus	Glaucoma IOPQTL Glaucoma, Susceptibility To Postinfectious Glaucoma Glaucoma With Ocular Inflammation Glaucoma Secondary To Eye Inflammation Traumatic Glaucoma Glaucoma With Concussion Of Globe Glaucoma Due To Ocular Trauma Glaucoma Associated With Ocular Trauma Glaucoma Secondary To Drugs
Igg4-Related Disease	Multifocal Fibrosclerosis Igg4-Related Sclerosing Disease Igg4-Related Systemic Disease Immunoglobulin G4-Related Sclerosing Disease Hyper-Igg4 Disease Igg4-Associated Disease Igg4-Positive Multiorgan Lymphoproliferative Syndrome Igg4-Related Autoimmune Disease Igg4-Related Systemic Sclerosing Disease Igg4-Syndrome Multifocal Idiopathic Fibrosclerosis Systemic Igg4-Related Plasmacytic Syndrome Systemic Igg4-Related Sclerosing Syndrome Mediastinal Fibrosis, Familial Retroperitoneal Fibrosis, Familial Igg4-Rd
Osteoporosis	Postmenopausal Osteoporosis Osteoporosis, Postmenopausal Bone Mineral Density Quantitative Trait Locus Bmnd Osteoporosis, Involutional Osteoporosis, Susceptibility To Osteoporosis, Postmenopausal, Susceptibility Bone Mineral Density Variation Qtl, Osteoporosis OSTEOP Involutional Osteoporosis Senile Osteoporosis Osteoporosis Postmenopausal Bone Mineral Density, Quantitative Trait Locus Osteoporosis, Senile Idiopathic Osteoporosis Bone Rarefaction Nos Type 1 Osteoporosis
Cone-Rod Dystrophy 2	Cone-Rod Dystrophy CORD2 Cone-Rod Retinal Dystrophy Rcrd2 Cone-Rod Retinal Dystrophy 2 Crd2 Cord Crd Retinal Cone-Rod Dystrophy Cone-Rod Retinal Dystrophy-2 Retinal Cone-Rod Dystrophy 2 Tapetoretinal Degeneration Cone-Rod Degeneration Cone Rod Dystrophy Dystrophy, Cone-Rod Dystrophy, Cone-Rod, Type 2 Retinitis Pigmentosa Retinitis Pigmentosa 2 Progressive Cone-Rod Dystrophy
Renal Tubular Transport Disease	Renal Tubular Transport, Inborn Errors Inborn Renal Tubular Transport Disorder
Autoimmune Pancreatitis	Lymphoplasmocytic Sclerosing Pancreatitis Aip
Mikulicz Disease	Igg4-Related Dacryoadenitis And Sialadenitis Mikulicz'S Disease Chronic Dacryoadenitis And Sialadenitis Mikulicz Syndrome Mikulicz' Disease
Autoimmune Cholangitis	Autoimmune Cholangiopathy
Renal Tubular Acidosis	Acidosis Renal Tubular Acidosis, Renal Tubular Lightwood-Albright Syndrome Lightwood Syndrome Idiopathic Infantile Hypercalcemia - Mild Form Kidney Tubular Acidosis Renal Tubule Acidosis Kidney Acidosis Renal Acidosis Renal Hyperchloremic Acidosis Rta - [Renal Tubular Acidosis]
Nephrocalcinosis	Hypercalcemic Nephropathy
Subacute Lymphocytic Thyroiditis
Osteopetrosis	Albers-Schonberg Disease Marble Bone Disease Osteopetroses Marble Bones Osteopetrosis And Related Disorders Congenital Osteopetrosis Marble Bone Albers-Schoenberg Disease Albers-Schonberg Osteopetrosis Osteosclerosis Fragilis Ivory Bones
Breast Cancer	Breast Carcinoma Breast Cancer, Familial Malignant Neoplasm Of Breast Male Breast Cancer Breast Cancer, Susceptibility To Breast Cancer, Early-Onset Malignant Tumor Of Breast Carcinoma Of Male Breast Breast Cancer, Invasive Ductal Breast Cancer, Protection Against Breast Cancer, Somatic Breast Cancer, Male Breast Cancer, Lobular, Somatic Breast Tumor Mammary Cancer Mammary Tumor Malignant Neoplasm Of Male Breast Mammary Carcinoma Male Breast Carcinoma Familial Cancer Of Breast Invasive Ductal Breast Carcinoma Breast Cancer Susceptibility Breast Cancer, Male, Susceptibility To Breast Cancer, Early-Onset, Susceptibility To Malignant Tumor Of The Breast Mammary Neoplasm Primary Breast Cancer Neoplasm Of Male Breast Carcinoma Of Breast Breast Cancer In Men Familial Breast Cancer Cancer Of Breast BC Breast Cancer Familial Breast Cancer Familial Male Breast Cancer, Familial Male Breast Male Carcinoma Breast Neoplasms Breast Neoplasms, Male Mammary Tumors Mammary Carcinomas Cancer, Breast Cancer, Breast, Susceptibility Invasive Breast Ductal Carcinoma Breast Neoplasm Susceptibility To Breast Cancer Mammary Neoplasms Animal Mammary Neoplasms Primary Malignant Neoplasm Of Breast Infiltrating Ductal Carcinoma Of Breast Infiltrating Duct Carcinoma Of Unspecified Site Infiltrating Ductular Carcinoma Of Unspecified Site Invasive Breast Carcinoma Of No Special Type Microinvasive Carcinoma Of Breast Carcinoma With Apocrine Differentiation
Metabolic Acidosis

Diseases	Alias
Waldenstroem'S Macroglobulinemia	Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma

Related Agents

Approval
Clinical Phase
Pre-clinical Phase

Approval

Bioactive Molecules (72)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-B0470	Neomycin sulfate	Inhibitor	99.92%	Unkown
HY-10341	Fasudil Hydrochloride		99.97%	Yes
HY-A0057	Gabapentin	Inhibitor	99.99%	Yes
HY-B0246	Carbamazepine		99.90%	Yes
HY-13764	Tetrandrine	Inhibitor	99.90%	Yes
HY-B0561	Spironolactone		99.81%	Yes
HY-12542	Dantrolene	Inhibitor	99.93%	Yes
HY-75161	(-)-Menthol	Activator	99.79%	Unkown
HY-B1193	Terfenadine		99.98%	Unkown
HY-B1077	Penfluridol		99.93%	Unkown
HY-B0632	Diltiazem	Inhibitor	99.70%	Yes
HY-B1221	Flufenamic acid		99.98%	Unkown
HY-17404	Cilnidipine	Inhibitor	99.89%	Yes
HY-10341A	Fasudil		99.98%	Yes
HY-14603	Clioquinol		99.84%	Unkown
HY-14656	Diltiazem hydrochloride	Antagonist	99.47%	Yes
HY-N1370	Tanshinone IIA sulfonate sodium	Inhibitor	99.77%	Unkown
HY-B1546A	Benzamil hydrochloride	Inhibitor	99.70%	Unkown
HY-75839	Dronedarone Hydrochloride		99.99%	Unkown
HY-15553A	Mibefradil dihydrochloride	Inhibitor	99.71%	Yes
HY-12542A	Dantrolene sodium hemiheptahydrate	Inhibitor	99.79%	Unkown
HY-A0057A	Gabapentin hydrochloride	Inhibitor	98.0%	Yes
HY-A0079	Tetracaine		99.87%	Unkown
HY-B1693	Levomepromazine		99.98%	Unkown
HY-B0358A	Flunarizine dihydrochloride		99.90%	Yes
HY-B0596	Taltirelin		99.91%	Unkown
HY-14657	Dantrolene sodium	Inhibitor	99.79%	Yes
HY-B0358	Flunarizine		99.79%	Yes
HY-B1424	Benzthiazide	Inhibitor	99.70%	Unkown
HY-A0082	Diphenidol hydrochloride	Antagonist	99.06%	Unkown
HY-16952A	Bepridil hydrochloride hydrate	Antagonist	99.86%	Unkown
HY-B0473	Tetracaine hydrochloride	Inhibitor	99.91%	Unkown
HY-B0246R	Carbamazepine (Standard)		99.97%	Unkown
HY-Y0258	Benzocaine		99.98%	Unkown
HY-Z0478	(-)-Limonene	Inhibitor	99.42%	Unkown
HY-103370	Talniflumate	Inhibitor	99.90%	Yes
HY-B0380	Trimebutine		99.42%	Yes
HY-107929	Calcium polystyrene sulfonate		/	Unkown
HY-B0380A	Trimebutine maleate		99.66%	Yes
HY-W042301	Xipamide		99.74%	Unkown
HY-Y0258A	Benzocaine (hydrochloride)	Modulator	99.83%	Unkown
HY-B0549A	Flavoxate hydrochloride		99.70%	Yes
HY-107319	Almitrine mesylate	Inhibitor	98.88%	Unkown
HY-121235	Clonixin	Inhibitor	98.88%	Unkown
HY-U00212	Aranidipine	Antagonist	99.12%	Unkown
HY-121186	Bevantolol hydrochloride	Antagonist	98.98%	Yes
HY-109545	Isopropyl unoprostone	Activator	98.42%	Unkown
HY-16216	Gabapentin enacarbil	Inhibitor	99.90%	Yes
HY-112961	Patiromer	Inhibitor	95.0%	Unkown
HY-A0135	Enflurane	Inhibitor	98.0%	Unkown
HY-A0236	Aprindine	Inhibitor	98.43%	Unkown
HY-B0596A	Taltirelin acetate		99.75%	Unkown
HY-P1769	Angiotensin II (5-8), human		99.74%	Unkown
HY-109106A	Upacicalcet sodium	Agonist	99.91%	Unkown
HY-B0549	Flavoxate		98.07%	Yes
HY-10341C	Fasudil dihydrochloride		99.98%	Yes
HY-15553	Mibefradil	Inhibitor	/	Unkown
HY-109106	Upacicalcet	Agonist	/	Unkown
HY-150520	Neomycin	Inhibitor	/	Unkown
HY-10341B	Fasudil hydrochloride semihydrate		/	Unkown
HY-106916	Unoprostone	Activator	99.0%	Unkown
HY-14656R	Diltiazem hydrochloride (Standard)	Antagonist	/	Unkown
HY-75839R	Dronedarone Hydrochloride (Standard)		/	Unkown
HY-A0270	Diphenidol	Antagonist	/	Unkown
HY-B0401A	Tolbutamide sodium	Inducer	/	Unkown
HY-B1546	Benzamil	Inhibitor	/	Unkown
HY-B1558	Bifemelane		/	Unkown
HY-P1792	Angiotensin II (1-4), human	Agonist	/	Unkown
HY-P1792A	Angiotensin II (1-4), human TFA	Agonist	/	Unkown
HY-121235R	Clonixin (Standard)	Inhibitor	/	Unkown
HY-B1693R	Levomepromazine (Standard)		/	Unkown
HY-Y0258AR	Benzocaine (hydrochloride) (Standard)		/	Unkown

Clinical Phase

Bioactive Molecules (57)

Cat. No.	Product Name	Effect	Purity	Phase
HY-N6687	Calcimycin		99.12%	Phase 4
HY-100560	Abscisic acid		99.78%	Phase 4
HY-W170020	PTCA	Ligand	99.72%	Phase 4
HY-50694	Senicapoc	Inhibitor	99.91%	Phase 3
HY-P0033	Argireline	Inhibitor	99.86%	Phase 3
HY-115864	Osavampator	Activator	99.74%	Phase 3
HY-Y0413	Biacetyl monoxime	Inhibitor	98.0%	Phase 3
HY-15724	Vercirnon	Antagonist	98.01%	Phase 3
HY-10805A	Almorexant hydrochloride		99.98%	Phase 3
HY-106449	Recoflavone		98.0%	Phase 3
HY-121872	DP-b99	Inhibitor	95.0%	Phase 3
HY-Z7721	(Rac)-Beraprost sodium	Inhibitor	99.0%	Phase 3
HY-106837	Israpafant	Antagonist	/	Phase 3
HY-113970	Nebracetam		/	Phase 3
HY-B1693A	Levomepromazine hydrochloride		/	Phase 3
HY-P5796	FS-2	Inhibitor	/	Phase 3
HY-118962	E913		/	Phase 3
HY-N1584	Halofuginone		99.28%	Phase 2
HY-101064	Fmoc-leucine		99.91%	Phase 2
HY-10007	NPS-2143	Antagonist	99.94%	Phase 2
HY-116330A	Hyperforin dicyclohexylammonium salt		99.48%	Phase 2
HY-10167A	Tecalcet Hydrochloride	Modulator	99.43%	Phase 2
HY-160023	Elisrasib		99.68%	Phase 2
HY-10066	Nelivaptan	Antagonist	99.89%	Phase 2
HY-B0340	Nefiracetam	Activator	99.87%	Phase 2
HY-135891	AZD2423	Antagonist	99.91%	Phase 2
HY-100779	Rimacalib	Inhibitor	99.14%	Phase 2
HY-100298	Caldaret	Inhibitor	98.35%	Phase 2
HY-100934	SC-9	Activator	99.33%	Phase 2
HY-147384	CXL-1020		≥99.0%	Phase 2
HY-105269A	Org 30029 hydrochloride	Activator	/	Phase 2
HY-106904	Nexopamil	Antagonist	/	Phase 2
HY-110312	JTV-519 fumarate		/	Phase 2
HY-113037B	Farnesyl pyrophosphate	Agonist	/	Phase 2
HY-12596	JNJ-26489112		99.31%	Phase 2
HY-169115	PD-0299685		/	Phase 2
HY-19397	BMS-223131		/	Phase 2
HY-W565924	STX107		/	Phase 2
HY-101616	ABT-639 hydrochloride	Inhibitor	/	Phase 2
HY-106415	Terflavoxate	Antagonist	/	Phase 2
HY-114826S	Prostaglandin E2-1-glyceryl ester-d5	Activator	/	Phase 2
HY-147301B	Resomelagon methanesulfonate	Agonist	/	Phase 2
HY-108496	Sphingosine-1-phosphate	Agonist	99.94%	Phase 1
HY-100973A	Adenosine 5′-diphosphoribose sodium		99.47%	Phase 1
HY-16935	Mavatrep	Antagonist	99.67%	Phase 1
HY-NP009	α-Lactalbumin	Inhibitor	99.9%	Phase 1
HY-129851	NTP42	Antagonist	98.58%	Phase 1
HY-120588	BI 639667	Antagonist	98.87%	Phase 1
HY-P4160	PDC31	Inhibitor	98.67%	Phase 1
HY-115681	(2R/S)-6-PNG	Inhibitor	99.96%	Phase 1
HY-133011	nAChR agonist 1	Agonist	98.35%	Phase 1
HY-13699	NBI-42902		98.65%	Phase 1
HY-114793	AL-12180	Agonist	/	Phase 1
HY-118148	UK-66914	Inhibitor	/	Phase 1
HY-147383	NS-8	Activator	/	Phase 1
HY-121701	SR33805 analog	Antagonist	/	Phase 1
HY-19062	SM-6586		/	Phase 1

Inhibitory Antibodies (1)

Cat. No.	Product Name	Effect	Purity	Phase
HY-P991646	ING-1		99.0%	Phase 1

Pre-clinical Phase

Bioactive Molecules (786)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-18723	Yoda 1		99.97%	Unkown
HY-13433	Thapsigargin		99.95%	Unkown
HY-100545	BAPTA-AM	Inhibitor	99.68%	Unkown
HY-112879	Mito-TEMPO		99.19%	Unkown
HY-101896	Fluo-4 AM		99.84%	Unkown
HY-W009724	2-Aminoethyl diphenylborinate		98.86%	Unkown
HY-D0989	Rhod-2 AM		≥97.0%	Unkown
HY-D0861	EGTA		99.89%	Unkown
HY-100202	TPEN		99.91%	Unkown
HY-N0219	Bicuculline	Antagonist	99.98%	Unkown
HY-19608	GSK1016790A		99.93%	Unkown
HY-100168	BAPTA	Inhibitor	98.04%	Unkown
HY-15084B	Dizocilpine	Antagonist	99.95%	Unkown
HY-126010	Dooku1	Antagonist	99.90%	Unkown
HY-10588	Bay K 8644	Agonist	99.96%	Unkown
HY-19805	STO-609	Inhibitor	98.20%	Unkown
HY-100831	YM-58483	Inhibitor	99.38%	Unkown
HY-P0221	PACAP (1-38), human, ovine, rat	Inducer	99.99%	Unkown
HY-12323	ISX-9	Activator	99.76%	Unkown
HY-D1024	Coelenterazine h		99.41%	Unkown
HY-138620	MCU-i4	Inhibitor	99.94%	Unkown
HY-101455	CDN1163	Activator	99.90%	Unkown
HY-119287	TSQ		99.50%	Unkown
HY-118630	Vacuolin-1	Inhibitor	98.54%	Unkown
HY-100912	W-7 hydrochloride		99.96%	Unkown
HY-101379A	8-Bromo-cGMP sodium	Inhibitor	99.89%	Unkown
HY-103312	Xestospongin C	Inhibitor	99.9%	Unkown
HY-P1410B	D-GsMTx4	Inhibitor	99.44%	Unkown
HY-123071	Box5	Antagonist	98.81%	Unkown
HY-Y0669	Pipecolic acid	Inhibitor	99.92%	Unkown
HY-15754	CGP37157	Inhibitor	99.87%	Unkown
HY-D1498	Mag-Fluo-4 AM		≥96.0%	Unkown
HY-D0973	EGTA-AM		99.81%	Unkown
HY-W019981B	Magnesium chloride hexahydrate, for molecular biology	Activator	99.40%	Unkown
HY-103319	Calmidazolium chloride	Antagonist	99.94%	Unkown
HY-100973	Adenosine 5′-diphosphoribose		98.21%	Unkown
HY-N6732	K-252a	Inhibitor	99.45%	Unkown
HY-101897	Fura-2 AM		≥99.0%	Unkown
HY-P0256	Apamin	Inhibitor	99.96%	Unkown
HY-P5912	GluN1(356-385)	Inhibitor	99.95%	Unkown
HY-50722	NNC 55-0396	Inhibitor	98.43%	Unkown
HY-15515	SEA0400	Inhibitor	99.95%	Unkown
HY-D0716	Fluo-3AM		≥99.0%	Unkown
HY-103474	Bicuculline methiodide	Inhibitor	99.93%	Unkown
HY-120691A	GSK205	Antagonist	99.47%	Unkown
HY-101044	PPADS tetrasodium		99.9%	Unkown
HY-113037C	Farnesyl pyrophosphate ammonium	Agonist	95.39%	Unkown
HY-N1502	Carboxyatractyloside tripotassium		99.97%	Unkown
HY-15124	(S)-(-)-Bay-K-8644	Agonist	99.22%	Unkown
HY-P10798A	Eloralintide sodium	Inhibitor	99.92%	Unkown
HY-108465	Pyr3	Inhibitor	99.83%	Unkown
HY-131614	TPC2-A1-N	Inhibitor	99.86%	Unkown
HY-107543	8-pCPT-2′-O-Me-cAMP sodium	Activator	99.81%	Unkown
HY-W019981C	Magnesium chloride hexahydrate, for cell culture	Activator	/	Unkown
HY-10805	Almorexant		99.96%	Unkown
HY-110105	NS8593 hydrochloride	Inhibitor	99.76%	Unkown
HY-N6778	Paxilline	Inhibitor	99.91%	Unkown
HY-P1410C	D-GsMTx4 TFA	Inhibitor	99.89%	Unkown
HY-P3419	PAMP-12 (unmodified)		99.40%	Unkown
HY-116522	AR420626		98.40%	Unkown
HY-108599	DCP-LA		98.0%	Unkown
HY-113328	Aminoadipic acid		99.94%	Unkown
HY-N6789	KT5720	Inhibitor	≥99.0%	Unkown
HY-103192	MDL12330A	Inhibitor	99.82%	Unkown
HY-101906	DC260126		99.57%	Unkown
HY-107411	Bromoenol lactone	Inhibitor	99.59%	Unkown
HY-135897	Urolithin C		98.00%	Unkown
HY-N1584A	Halofuginone hydrobromide		99.85%	Yes
HY-16697	CID 16020046	Antagonist	99.81%	Unkown
HY-N0043	Ginsenoside Rd	Inhibitor	99.88%	Unkown
HY-125944	MitoTEMPO hydrate		98.03%	Unkown
HY-133168	Englerin A	Activator	99.50%	Unkown
HY-P5712	Gramicidin S	Inhibitor	99.89%	Unkown
HY-W018035	DL-Glyceric Acid (20% in water)		≥97.0%	Unkown
HY-116429	Maresin 1	Inhibitor	99.03%	Unkown
HY-15416	NS309	Activator	99.09%	Unkown
HY-12949	ML204	Inhibitor	98.45%	Unkown
HY-B2149	Quadrol	Activator	99.96%	Unkown
HY-101017	Palmitoylcarnitine chloride		98.0%	Unkown
HY-103660	18:0 LYSO-PE		99.0%	Unkown
HY-111208	CCT129957	Inhibitor	99.16%	Unkown
HY-N2522	Carboxyatractyloside dipotassium		99.57%	Unkown
HY-131648	1-Oleoyl-2-acetyl-sn-glycerol	Activator	99.90%	Unkown
HY-W194810	MCU-i11		98.05%	Unkown
HY-13103	NS 11021	Activator	99.51%	Unkown
HY-149662	TMDJ-035	Inhibitor	99.92%	Unkown
HY-162501	Yaddle1	Agonist	99.98%	Unkown
HY-P0190	Iberiotoxin	Inhibitor	99.71%	Unkown
HY-114252	Strophanthidin	Inhibitor	98.71%	Unkown
HY-123071A	Box5 TFA	Antagonist	99.50%	Unkown
HY-15415	KB-R7943 mesylate	Inhibitor	99.16%	Unkown
HY-Y1667	2,6-Dibromophenol	Inhibitor	99.76%	Unkown
HY-100168B	BAPTA tetrapotassium	Inhibitor	99.42%	Unkown
HY-103306	Ryanodine		99.91%	Unkown
HY-14229	TGR5 Receptor Agonist	Agonist	99.67%	Unkown
HY-120261	GB-88	Inhibitor	98.66%	Unkown
HY-P1080A	ω-Agatoxin IVA TFA	Inhibitor	99.52%	Unkown
HY-N0515	Ophiopogonin D		99.80%	Unkown
HY-N0601	Ginsenoside Rf	Inhibitor	99.48%	Unkown
HY-107582	JW480	Inhibitor	99.82%	Unkown
HY-119401	CAY10444	Antagonist	98.0%	Unkown
HY-162426	UNC-CA2-103	Inhibitor	99.26%	Unkown
HY-P1345A	TLQP-21 TFA	Agonist	99.90%	Unkown
HY-100168A	BAPTA tetrasodium	Inhibitor	99.70%	Unkown
HY-P3278	Caloxin 2A1	Inhibitor	99.97%	Unkown
HY-D0861A	EGTA tetrasodium		99.93%	Unkown
HY-103307	FPL64176	Agonist	99.86%	Unkown
HY-107658	SN 6	Inhibitor	99.66%	Unkown
HY-N0607	Ginsenoside Ro		99.81%	Unkown
HY-W017387	Sodium α-ketoisocaproate		98.0%	Unkown
HY-157562	DS68591889		99.18%	Unkown
HY-12496	NS-1619		98.06%	Unkown
HY-137790	Bicuculline methochloride	Antagonist	99.80%	Unkown
HY-15292	S107	Ligand	99.77%	Unkown
HY-B0006C	(R)-Carvedilol	Inhibitor	98.78%	Unkown
HY-D1903	Fura Red AM		91.00%	Unkown
HY-P2847	Urocortin II, mouse	Agonist	99.94%	Unkown
HY-16690	BTS	Inhibitor	99.79%	Unkown
HY-136409	N-Decanoyl-L-homoserine lactone		98.40%	Unkown
HY-10171	NPS-2143 hydrochloride	Antagonist	99.98%	Unkown
HY-106844A	(+)-EMD 57033		99.72%	Unkown
HY-126750	GNF362	Inhibitor	99.86%	Unkown
HY-N0663	Talatisamine		99.77%	Unkown
HY-N2344	Procyanidin A1	Inhibitor	99.96%	Unkown
HY-NP164	Concanavalin A-HRP		/	Unkown
HY-W011235	Norfluoxetine hydrochloride		99.54%	Unkown
HY-128747	α-D-Glucose-1-phosphate disodium		99.93%	Unkown
HY-16689	VU 0240551	Inhibitor	99.70%	Unkown
HY-D1422	ER Tracker Yellow		96.91%	Unkown
HY-19408	Pyr10	Inhibitor	99.95%	Unkown
HY-103309	ML218	Inhibitor	99.49%	Unkown
HY-19749	PD 151746	Inhibitor	95.03%	Unkown
HY-101366	A-61603	Agonist	99.34%	Unkown
HY-P3278A	Caloxin 2A1 TFA	Inhibitor	99.92%	Unkown
HY-15293B	JTV-519 hemifumarate	Inhibitor	99.74%	Unkown
HY-124416	ML604086	Inhibitor	99.78%	Unkown
HY-160099	20-5,14-HEDE		98.34%	Unkown
HY-N2500	Deoxypodophyllotoxin		99.86%	Unkown
HY-P1821	Myelin Basic Protein		99.55%	Unkown
HY-120026	KB130015		98.45%	Unkown
HY-16992A	W-54011		99.57%	Unkown
HY-120597	SAK3	Activator	99.80%	Unkown
HY-15671	GKA50	Activator	99.84%	Unkown
HY-DY1020	Rhod-2 AM (solution)		/	Unkown
HY-N0126	Xanthone	Inhibitor	99.97%	Unkown
HY-120528A	GB-110 hydrochloride	Agonist	99.86%	Unkown
HY-130311	2-Linoleoyl glycerol	Inhibitor	99.9%	Unkown
HY-103320A	Calhex 231 hydrochloride	Inhibitor	99.81%	Unkown
HY-101015A	OBAA		99.31%	Unkown
HY-18071	BI-9627	Inhibitor	99.71%	Unkown
HY-N0724	Mesaconitine	Activator	99.19%	Unkown
HY-N7690	3,5,7,3′,4′-Pentamethoxyflavone	Inhibitor	99.69%	Unkown
HY-P0190A	Iberiotoxin TFA	Inhibitor	99.43%	Unkown
HY-W001538	S-Propargylcysteine		97.0%	Unkown
HY-157453	CCR4 antagonist 4	Antagonist	98.92%	Unkown
HY-101360	1-EBIO	Agonist	99.96%	Unkown
HY-N0910	Notoginsenoside Ft1		99.49%	Unkown
HY-100712	DPO-1	Inhibitor	98.39%	Unkown
HY-101329	Anthracene-9-carboxylic acid	Inhibitor	99.21%	Unkown
HY-103316A	Ned 19	Inhibitor	99.92%	Unkown
HY-115719	NR162	Inhibitor	99.7%	Unkown
HY-14350	AC-55541	Agonist	99.40%	Unkown
HY-15724A	Vercirnon sodium	Antagonist	98.04%	Unkown
HY-N0252	Catharanthine	Inhibitor	99.46%	Unkown
HY-P1366	des-Gln14-Ghrelin		98.21%	Unkown
HY-136460	Calcium ionophore I		99.6%	Unkown
HY-162774A	GRP75-IN-1 dihydrochloride	Inducer	99.75%	Unkown
HY-N0392	Polygalasaponin F		99.85%	Unkown
HY-N2081	Skimmianine	Inhibitor	99.90%	Unkown
HY-N6066	Praeruptorin E		99.83%	Unkown
HY-N8307	Syringaresinol		99.66%	Unkown
HY-P10655	Caloxin 1C2	Inhibitor	99.47%	Unkown
HY-W131725	(+)-Norfenfluramine	Agonist	98.79%	Unkown
HY-16639	ML314	Agonist	99.52%	Unkown
HY-118010A	(+)-Norfenfluramine hydrochloride	Agonist	99.77%	Unkown
HY-34740	Ethylmalonic acid	Inhibitor	98.0%	Unkown
HY-114400	TRPV4 agonist-1 free base	Agonist	99.69%	Unkown
HY-130118	MRGPRX1 agonist 1	Agonist	99.95%	Unkown
HY-108593	BMS-191011	Activator	99.56%	Unkown
HY-131900	Protein kinase inhibitor H-7	Inhibitor	99.96%	Unkown
HY-158779	Sulfane sulfur probe 4		97.3%	Unkown
HY-D1024A	Coelenterazine h hydrochloride		99.65%	Unkown
HY-N0084	Betulinaldehyde	Inhibitor	98.72%	Unkown
HY-N0642	α-L-Rhamnose monohydrate	Activator	98.0%	Unkown
HY-N4104	Agaric acid		99.45%	Unkown
HY-N7063	Nerol		98.97%	Unkown
HY-P1075	CALP3	Inhibitor	99.55%	Unkown
HY-P1341	OXA(17-33)		97.48%	Unkown
HY-W041308	DCOIT	Agonist	99.87%	Unkown
HY-W110910	Eriochrome black T, Indicator		/	Unkown
HY-12498	GV-58	Agonist	99.22%	Unkown
HY-147301	Resomelagon	Agonist	98.79%	Unkown
HY-108608	o-3M3FBS		99.79%	Unkown
HY-116291	4α-Phorbol 12,13-didecanoate		99.30%	Unkown
HY-124873	SERCA2a activator 1	Activator	99.71%	Unkown
HY-128747A	α-D-Glucose-1-phosphate disodium hydrate		98.0%	Unkown
HY-12927	SX-517	Antagonist	99.90%	Unkown
HY-34740S	Ethylmalonic acid-d3	Inhibitor	98.0%	Unkown
HY-Y1422I	Lipase,Pseudomonas fluorescens (Immobilized)		/	Unkown
HY-101396	ICA-069673	Activator	99.20%	Unkown
HY-100783	(-)-Bicuculline methobromide	Antagonist	99.94%	Unkown
HY-104058	BAPTA Green 1AM		92.0%	Unkown
HY-110018	N-Arachidonyldopamine		98.36%	Unkown
HY-P3965	16-38-Thymosin β4 (cattle)	Activator	98.05%	Unkown
HY-W010710	IPrAuCl	Inhibitor	98.2%	Unkown
HY-12949A	ML204 hydrochloride	Inhibitor	99.74%	Unkown
HY-103442	CGP52411	Inhibitor	99.82%	Unkown
HY-108464A	Phenamil methanesulfonate	Inhibitor	98.1%	Unkown
HY-117073	ITH12575	Inhibitor	98.84%	Unkown
HY-135556	Norfluoxetine		98.71%	Unkown
HY-136661	(-)-N6-Phenylisopropyl adenosine	Agonist	99.45%	Unkown
HY-175416	Yoda2	Agonist	99.57%	Unkown
HY-D0202	Arsenazo III		95.0%	Unkown
HY-DY1028	Fluo-4 AM (solution)		/	Unkown
HY-E70200	Recombinant Kex2 protease		/	Unkown
HY-N2060	Evocarpine		99.88%	Unkown
HY-P1077A	CALP1 TFA		98.15%	Unkown
HY-P1821A	Myelin basic protein (4-14) TFA		99.41%	Unkown
HY-W012399	2,5-Di-tert-butylhydroquinone		99.73%	Unkown
HY-W181102	NFAT Inhibitor-2	Inhibitor	98.42%	Unkown
HY-137175	TMBIM6 antagonist-1	Antagonist	98.92%	Unkown
HY-100656	Desmethyl cariprazine	Antagonist	98.08%	Unkown
HY-103317	NAADP		95.8%	Unkown
HY-108496S	Sphingosine-1-phosphate-d7	Agonist	99.9%	Unkown
HY-108607	PACOCF3	Inhibitor	98.0%	Unkown
HY-113037CS	Farnesyl pyrophosphate-d2 triammonium	Agonist	95.78%	Unkown
HY-135746	OR-1896		99.04%	Unkown
HY-B1671	(+)-Kavain		99.98%	Unkown
HY-D0110A	Fura-2 pentapotassium		97.0%	Unkown
HY-N1584C	Halofuginone lactate		98.32%	Yes
HY-N6688	Verruculogen	Inhibitor	98.08%	Unkown
HY-P1831	Proadrenomedullin (1-20), human		99.53%	Unkown
HY-P5189A	His-D-beta-Nal-Ala-Trp-D-Phe-Lys-NH2 TFA		99.94%	Unkown
HY-N7491A	Ent-(+)-Verticilide	Inhibitor	99.91%	Unkown
HY-110153	NS19504	Activator	99.93%	Unkown
HY-125703	Ferutinin		99.23%	Unkown
HY-128678	ORM-10103	Inhibitor	99.43%	Unkown
HY-136909	SR33805	Antagonist	99.78%	Unkown
HY-146268	CaMKIIα-IN-1	Inhibitor	98.53%	Unkown
HY-161104	Kv2.1-IN-1	Inhibitor	98.64%	Unkown
HY-P0271A	Syntide 2 TFA		99.70%	Unkown
HY-P1076A	CALP2 TFA	Antagonist	98.31%	Unkown
HY-P1080	ω-Agatoxin IVA	Inhibitor	98.71%	Unkown
HY-P1247	Calcineurin autoinhibitory peptide	Inhibitor	99.99%	Unkown
HY-P3187	exo-β-1,4-Xylosidase, Cellulosimicrobium cellulans sp. 21		/	Unkown
HY-W017387S	Sodium α-ketoisocaproate-d3		98.48%	Unkown
HY-19721	ABT-639	Inhibitor	98.67%	Unkown
HY-105118A	Zaldaride maleate	Antagonist	99.7%	Unkown
HY-103544	[D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P		99.75%	Unkown
HY-108592	UCL 2077	Inhibitor	98.91%	Unkown
HY-110292	A-425619		99.96%	Unkown
HY-111527	PPZ2		99.92%	Unkown
HY-121584	Lycoperodine-1	Agonist	99.82%	Unkown
HY-136182	YM-244769 dihydrochloride	Inhibitor	98.57%	Unkown
HY-136182A	YM-244769	Inhibitor	99.22%	Unkown
HY-155480	PSB-22034	Agonist	99.61%	Unkown
HY-E70234A	Sortase A, S. aureus (non-Ca²⁺-dependent)		96.90%	Unkown
HY-N1940	β-Anhydroicaritin	Inhibitor	99.69%	Unkown
HY-N2157	Pteryxin	Inhibitor	99.55%	Unkown
HY-NP164B	Concanavalin A-AF488		/	Unkown
HY-P2757	Phosphorylase kinase		/	Unkown
HY-P3617	Glucagon (22-29)	Agonist	98.12%	Unkown
HY-41076	Ca2+ channel agonist 1		98.87%	Unkown
HY-D0077	2',7'-Difluorofluorescein		99.52%	Unkown
HY-N0742	Absinthin	Agonist	98.0%	Unkown
HY-165607S	MCB-22-174		99.78%	Unkown
HY-103277A	BIM 23042 TFA	Antagonist	99.75%	Unkown
HY-103317A	NAADP tetrasodium		99.1%	Unkown
HY-118824A	N-Feruloylserotonin	Inhibitor	99.93%	Unkown
HY-12550	GW542573X	Activator	99.79%	Unkown
HY-126583	Nemadipine-A	Inhibitor	98.87%	Unkown
HY-130368	W-7		99.35%	Unkown
HY-136190	TRPC6-PAM-C20	Agonist	99.78%	Unkown
HY-149483	CVN417	Antagonist	99.93%	Unkown
HY-A0236A	Aprindine hydrochloride	Inhibitor	98.96%	Unkown
HY-D0121A	INDO 1 pentapotassium		96.43%	Unkown
HY-N7117	1,4-Cineole	Activator	95.0%	Unkown
HY-P0256A	Apamin TFA	Inhibitor	97.49%	Unkown
HY-P3037A	Imperatoxin A TFA	Activator	98.25%	Unkown
HY-W013857	Lavendustin C	Inhibitor	98.17%	Unkown
HY-W344044	Levomepromazine maleate		99.92%	Unkown
HY-100928	YS 035 hydrochloride	Antagonist	99.15%	Unkown
HY-137172	ETH 157		99.52%	Unkown
HY-141581	Lyso-PAF C-18	Modulator	99.74%	Unkown
HY-103320B	(1R,2R)-Calhex 231 hydrochloride	Control	98.45%	Unkown
HY-10388A	TTA-Q6(isomer)		99.91%	Unkown
HY-107855S	DL-Mevalonolactone-d7		99.27%	Unkown
HY-110140	(E)-KN-93 phosphate	Inhibitor	99.85%	Unkown
HY-119282	AZD6538	Inhibitor	/	Unkown
HY-129496	NP-313	Inhibitor	99.31%	Unkown
HY-131012	GoSlo-SR-5-69	Activator	99.26%	Unkown
HY-131041	Ned-K		99.35%	Unkown
HY-13338	Mabuterol	Agonist	99.96%	Unkown
HY-174140	VU0514009	Antagonist	99.53%	Unkown
HY-175593	M6766		99.43%	Unkown
HY-176710	PAD-PF2		99.94%	Unkown
HY-18071A	BI-9627 hydrochloride	Inhibitor	98.01%	Unkown
HY-B0246S4	Carbamazepine-d4		99.72%	Unkown
HY-N9404	6-Benzoylheteratisine	Inhibitor	99.58%	Unkown
HY-P1079	ω-Agatoxin TK	Inhibitor	≥99.0%	Unkown
HY-P1250	RFRP-3(human)	Agonist	99.43%	Unkown
HY-P1387	β-Amyloid (1-40) (rat)	Inducer	/	Unkown
HY-P1805	Calmodulin Binding Peptide 1	Ligand	98.68%	Unkown
HY-W134005	Mg(Ⅱ)-EDTA disodium tetrahydrate		99.16%	Unkown
HY-W641445	ELP-004	Inhibitor	99.89%	Unkown
HY-100656AS	Desmethyl cariprazine-d8		99.93%	Unkown
HY-126789A	DM-Nitrophen tertasodium		90.0%	Unkown
HY-130309	(±)8(9)-EpETE		99.9%	Unkown
HY-W010252	N-Benzylethylenediamine		99.79%	Unkown
HY-W1113135	Carboxymethyl-β-cyclodextrin sodium salt		99.6%	Unkown
HY-14656S	Diltiazem-d3 hydrochloride	Antagonist	98.70%	Unkown
HY-100402	CFMTI	Antagonist	98.0%	Unkown
HY-101390	(+)-Niguldipine hydrochloride	Ligand	98.06%	Unkown
HY-103472	FPR-A14	Agonist	98.58%	Unkown
HY-11000A	CaMKP inhibitor sodium	Inhibitor	98.06%	Unkown
HY-111014	VK-II-36	Activator	99.62%	Unkown
HY-115767	(±)-1,2-Diolein	Activator	97.0%	Unkown
HY-145384	ROC-0929	Inhibitor	99.62%	Unkown
HY-147005	piCRAC-1	Inhibitor	99.36%	Unkown
HY-147301A	Resomelagon acetate	Agonist	99.15%	Unkown
HY-155516	KV1.3-IN-1	Inhibitor	98.34%	Unkown
HY-15705	GPR35 agonist 2		98.61%	Unkown
HY-173537	D-myo-Inositol-1,2,4,5-tetraphosphate tetrasodium salt		98.0%	Unkown
HY-176745	SW016789	Inducer	99.85%	Unkown
HY-B0493S1	Niflumic acid-13C6	Inhibitor	99.8%	Unkown
HY-B1221S1	Flufenamic acid-13C6		/	Unkown
HY-D1631	Calcium Green-5N AM		/	Unkown
HY-DY1095	Fluo-3AM (solution)		/	Unkown
HY-N0126R	Xanthone (Standard)	Inhibitor	99.99%	Unkown
HY-N0215S14	L-Phenylalanine-15N,d8	Antagonist	99.90%	Unkown
HY-N4237	Saikogenin D		99.99%	Unkown
HY-P1077	CALP1		98.44%	Unkown
HY-P11292	Caloxin 1b3	Inhibitor	99.81%	Unkown
HY-P1397A	RVD-Hpα TFA	Agonist	98.92%	Unkown
HY-P1640	(Trp63,Trp64)-C3a(63-77)	Agonist	99.23%	Unkown
HY-P3811A	Autocamtide-3 acetate		99.95%	Unkown
HY-P5142A	ω-Hexatoxin-Hv1a TFA	Inhibitor	97.49%	Unkown
HY-W748509	Pipernonaline		99.30%	Unkown
HY-101329S	Anthracene-9-carboxylic acid-d9		98.01%	Unkown
HY-126789	DM-Nitrophen		98.40%	Unkown
HY-154924	Thio-NADP		96.57%	Unkown
HY-15515R	SEA0400 (Standard)	Inhibitor	98.11%	Unkown
HY-N16129	Diplacone		98.38%	Unkown
HY-Y0258S	Benzocaine-d4		99.34%	Unkown
HY-101902	Quin-2AM		/	Unkown
HY-101015	(2E)-OBAA		/	Unkown
HY-101428	NS-638	Inhibitor	99.84%	Unkown
HY-101693A	Senazodan hydrochloride	Inhibitor	99.84%	Unkown
HY-103308	TRAM-39	Inhibitor	99.66%	Unkown
HY-10388	TTA-Q6	Antagonist	99.97%	Unkown
HY-104056	Fura Red		/	Unkown
HY-107659	YM-244769 hydrochloride	Inhibitor	98.09%	Unkown
HY-107678	SEN12333	Agonist	98.45%	Unkown
HY-108515	(R)-Igmesine hydrochloride		99.0%	Unkown
HY-112741	SB-209247	Antagonist	99.33%	Unkown
HY-113970A	Nebracetam hydrochloride		99.0%	Unkown
HY-115745	Calmodulin antagonist-1	Antagonist	98.0%	Unkown
HY-120514	JNc-440		98.04%	Unkown
HY-120528	GB-110	Agonist	/	Unkown
HY-121604	(Rac)-MEM 1003	Inhibitor	99.64%	Unkown
HY-124176	L-6355		/	Unkown
HY-131040	NLRP3-IN-NBC6	Inhibitor	99.40%	Unkown
HY-131948	3-Chlorodiphenylamine	Activator	98.74%	Unkown
HY-132190	Hexanolamino PAF C-16	Antagonist	99.9%	Unkown
HY-135110	Rp-8-Br-cGMPS sodium		99.9%	Unkown
HY-136395	Cartap	Inducer	/	Unkown
HY-141712	ZA18	Inhibitor	99.72%	Unkown
HY-147377	N-Salicyloyltryptamine		96.37%	Unkown
HY-15293	JTV-519	Inhibitor	98.0%	Unkown
HY-15293A	JTV-519 free base	Inhibitor	/	Unkown
HY-15671A	GKA50 quarterhydrate	Activator	≥98.0%	Unkown
HY-16489A	Terodiline hydrochloride	Antagonist	99.78%	Unkown
HY-173191	SK-124	Inhibitor	95.0%	Unkown
HY-19857	Sulcardine sulfate		/	Unkown
HY-B0561S4	Spironolactone-d6-1		99.26%	Unkown
HY-B1837A	β-Cyfluthrin	Inhibitor	99.94%	Unkown
HY-B1873	Methoxychlor	Inducer	99.41%	Unkown
HY-DY1101	Fura-2 AM (solution)		/	Unkown
HY-N0252A	Catharanthine Tartrate	Inhibitor	98.88%	Unkown
HY-N0252B	Catharanthine Sulfate	Inhibitor	/	Unkown
HY-N10116A	Calamenene		/	Unkown
HY-N10772	Albanin A	Inhibitor	97.67%	Unkown
HY-N1989	Bacoside A		/	Unkown
HY-N2359	Chelerythrine		/	Unkown
HY-N4267	Yangambin		98.27%	Unkown
HY-N7063R	Nerol (Standard)		/	Unkown
HY-N7875	Celangulin		95.93%	Unkown
HY-NP164L	Concanavalin A-AF647		/	Unkown
HY-P0271	Syntide 2		/	Unkown
HY-P1479A	Calmodulin-Dependent Protein Kinase II(290-309) acetate		98.45%	Unkown
HY-P3037	Imperatoxin A	Activator	/	Unkown
HY-P3965A	16-38-Thymosin β4 (cattle) TFA	Activator	98.14%	Unkown
HY-P5154A	Tamapin TFA	Antagonist	98.79%	Unkown
HY-P5914	Wasabi Receptor Toxin	Activator	/	Unkown
HY-P5914A	Wasabi Receptor Toxin TFA	Activator	99.49%	Unkown
HY-P5988	N-myristoyl-RKRTLRRL	Inhibitor	99.37%	Unkown
HY-P6013A	wt hMLN TFA	Inhibitor	95.0%	Unkown
HY-Q40876	BBT	Modulator	99.71%	Unkown
HY-W250149	Chlorophosphonazo III		/	Unkown
HY-Y0258R	Benzocaine (Standard)		99.99%	Unkown
HY-Y0258S1	Benzocaine-(ethyl-d5)		99.0%	Unkown
HY-Y1422E	Lipase,Aspergillusniger (Immobilized)		/	Unkown
HY-101693	Senazodan	Inhibitor	/	Unkown
HY-12962	NMDA-IN-1	Antagonist	98.98%	Unkown
HY-132191	Pradimicin A	Inhibitor	/	Unkown
HY-150135B	D-myo-Inositol 1,4,5-trisphosphate tripotassium	Activator	98.00%	Unkown
HY-B1193S	Terfenadine-d3		99.06%	Unkown
HY-W011235S	Norfluoxetine-d5 hydrochloride		99.30%	Unkown
HY-W400427	α-D-Glucose-1-phosphate		≥97.0%	Unkown
HY-W654243	Isovalerylcarnitine-d9-1 chloride	Activator	99.55%	Unkown
HY-114400A	TRPV4 agonist-1	Agonist	/	Unkown
HY-102085	11-Deoxyglycyrrhetinic acid sodium	Activator	/	Unkown
HY-103309A	ML218 hydrochloride	Inhibitor	/	Unkown
HY-125836	CCR4 antagonist 2	Antagonist	/	Unkown
HY-184055	NMDA receptor antagonist-12	Antagonist	/	Unkown
HY-19805A	STO-609 acetate	Inhibitor	/	Unkown
HY-N1584B	Halofuginone hydrochloride		/	Unkown
HY-135556AS	Norfluoxetine-d5		/	Unkown
HY-B0632S	Diltiazem-d6	Antagonist	/	Unkown
HY-P2471	Neurogranin (48-76), mouse	Inhibitor	/	Unkown
HY-10050	CJ-17493	Antagonist	/	Unkown
HY-100783A	(+)-Bicuculline methochloride	Antagonist	/	Unkown
HY-100783B	Bicuculline methobromide	Antagonist	/	Unkown
HY-100981	MR-16728 hydrochloride		/	Unkown
HY-10167	Tecalcet	Modulator	/	Unkown
HY-101685A	Iganidipine dihydrochloride	Antagonist	/	Unkown
HY-103277	BIM 23042	Antagonist	/	Unkown
HY-103309S	ML218-d9	Inhibitor	/	Unkown
HY-103313	SR33805 oxalate	Antagonist	/	Unkown
HY-103320	Calhex 231	Antagonist	/	Unkown
HY-103545	GIP (1-39)	Agonist	/	Unkown
HY-103660S	18:0 LYSO-PE-d35		/	Unkown
HY-105118	Zaldaride	Inhibitor	/	Unkown
HY-105402	T 162559	Inhibitor	/	Unkown
HY-105415	U 92032	Inhibitor	/	Unkown
HY-106428	Icrocaptide	Inhibitor	/	Unkown
HY-106525	Aclatonium napadisylate	Agonist	/	Unkown
HY-106818A	Monatepil maleate		/	Unkown
HY-107855S1	DL-Mevalonolactone-d3		/	Unkown
HY-108659	NF340		/	Unkown
HY-109106B	(Rac)-Upacicalcet		95.0%	Unkown
HY-111198	YM-355179 fumarate		/	Unkown
HY-111214	K-14585		/	Unkown
HY-113920	Azumolene sodium	Inhibitor	/	Unkown
HY-114554	KS 619-1	Inhibitor	/	Unkown
HY-114691	R 59494	Inhibitor	/	Unkown
HY-114743	GS 283	Antagonist	/	Unkown
HY-114826	Prostaglandin E2-1-glyceryl ester	Activator	/	Unkown
HY-115493	TIQ-15	Antagonist	/	Unkown
HY-116153	HUHS2002		/	Unkown
HY-116312	8-pCPT-2′-O-Me-cAMP	Activator	/	Unkown
HY-116330	Hyperforin		/	Unkown
HY-116429A	7(S)-Maresin 1		/	Unkown
HY-116429S	Maresin 1-d5	Inhibitor	/	Unkown
HY-116500A	AH-1058	Antagonist	/	Unkown
HY-116540	L 858051	Activator	/	Unkown
HY-116540A	L 858051 dihydrochloride	Activator	/	Unkown
HY-117099	TMB-8	Antagonist	98.0%	Unkown
HY-118817	Evariquinone	Inhibitor	/	Unkown
HY-119386	SAS-0132		/	Unkown
HY-119850A	Aladorian sodium	Modulator	/	Unkown
HY-120699	RO5488608	Modulator	/	Unkown
HY-120820	LY320954	Antagonist	/	Unkown
HY-120985	Araguspongin B	Antagonist	/	Unkown
HY-121235S1	Clonixin-13C,d3	Inhibitor	/	Unkown
HY-121516	CM-TPMF		99.91%	Unkown
HY-12153	JNJ-1930942	Modulator	/	Unkown
HY-12155	JNJ-26990990	Inhibitor	/	Unkown
HY-121690	Semotiadil	Antagonist	/	Unkown
HY-121966	Riparin		98.00%	Unkown
HY-12292G	IM-12 (GMP)		/	Unkown
HY-123659	KR-33028	Inhibitor	/	Unkown
HY-12542S	Dantrolene-13C3	Inhibitor	99.0%	Unkown
HY-125641A	AL-34662 formate	Agonist	/	Unkown
HY-126821	Fluo-3		/	Unkown
HY-126821A	Fluo-3 pentaammonium		/	Unkown
HY-128547	Cetiedil citrate		/	Unkown
HY-129088	HUP30		99.68%	Unkown
HY-129547	Fluo-3 pentapotassium		/	Unkown
HY-12962A	NMDA-IN-1 dihydrochloride	Antagonist	/	Unkown
HY-130070	QO-40	Activator	98.77%	Unkown
HY-131001	DPNB-ABT594	Agonist	/	Unkown
HY-131691	NMDAR blocker 1		/	Unkown
HY-131942	sFTX-3.3	Antagonist	/	Unkown
HY-132227	Dichlorobenzamil hydrochloride	Inhibitor	/	Unkown
HY-133596	12,14-Dichlorodehydroabietic acid		/	Unkown
HY-135433	MAPTAM		/	Unkown
HY-135478	LY393615	Inhibitor	/	Unkown
HY-135746S	OR-1896-d3		/	Unkown
HY-136189	UK-59811 hydrochloride	Inhibitor	/	Unkown
HY-136283	DMNPE-4 AM-caged-calcium	Ligand	/	Unkown
HY-136894	Rhod-5N		/	Unkown
HY-137203	(+)-Niguldipine		/	Unkown
HY-13764A	dl-Tetrandrine	Inhibitor	/	Unkown
HY-137952	NS8593	Inhibitor	/	Unkown
HY-138951	AY77	Agonist	/	Unkown
HY-138990	GK563	Inhibitor	/	Unkown
HY-139041	Palmitoylcholine chloride	Inhibitor	99.52%	Unkown
HY-141581S	Lyso-PAF C-18-d4	Modulator	/	Unkown
HY-141713	ZA10	Inhibitor	/	Unkown
HY-142050	(R)-IDHP		/	Unkown
HY-142087	Beauverolide Ja	Inhibitor	/	Unkown
HY-142117	Adenophostin A	Activator	/	Unkown
HY-145196	RTICBM-189	Modulator	99.73%	Unkown
HY-145385	Coelenteramide		/	Unkown
HY-145900	S100A2-p53-IN-1	Inhibitor	/	Unkown
HY-146232	F 13714	Agonist	/	Unkown
HY-146461	Anticancer agent 58		/	Unkown
HY-146462	Anticancer agent 59		/	Unkown
HY-14656S1	Diltiazem-(acetoxy-d3) hydrochloride	Antagonist	/	Unkown
HY-14656S4	Diltiazem-d4-1 hydrochloride	Antagonist	/	Unkown
HY-147186	5,5'-Difluoro BAPTA		/	Unkown
HY-150039	CCG-271423	Inhibitor	/	Unkown
HY-15016	(E/Z)-OT-R antagonist 1	Antagonist	/	Unkown
HY-15018A	SSR126768A free base	Antagonist	/	Unkown
HY-151451	Cav 3.2 inhibitor 2	Inhibitor	/	Unkown
HY-151452	Cav 3.2 inhibitor 3	Inhibitor	/	Unkown
HY-151547	MRS4719	Antagonist	/	Unkown
HY-151547S	MRS4719-d3		/	Unkown
HY-156082	RyRs activator 3	Inhibitor	/	Unkown
HY-156104	CaMKIIα-PHOTAC	Degrader	/	Unkown
HY-160099S	20-5,14-HEDE-d2		/	Unkown
HY-160099S1	20-5,14-HEDE-d2-1		/	Unkown
HY-160099S2	20-5,14-HEDE-d2-2		/	Unkown
HY-160508	NCX1-IN-1	Inhibitor	/	Unkown
HY-160998	YM-344031	Antagonist	/	Unkown
HY-161388	NSCLC-IN-1	Inducer	/	Unkown
HY-162280	PROTAC BTK Degrader-9		/	Unkown
HY-162374	ANO61	Inhibitor	/	Unkown
HY-162375	AF299		/	Unkown
HY-162774	GRP75-IN-1	Inducer	/	Unkown
HY-164682	AMD 3329 octahydrobromide	Inhibitor	/	Unkown
HY-164684	Dichlorobenzamil	Inhibitor	/	Unkown
HY-166363S	Beraprost-d3		/	Unkown
HY-166562S	Levomepromazine-d6 hydrochloride		/	Unkown
HY-167091	(Rac)-Beraprost		/	Unkown
HY-169115A	(Rac)-PD0299685	Ligand	/	Unkown
HY-169206	PF-3166	Inhibitor	/	Unkown
HY-169845	Calcium Channel antagonist 6	Antagonist	/	Unkown
HY-170424	D-myo-Inositol-1,3,4,5-tetrakisphosphate potassium		/	Unkown
HY-170801	Anticonvulsant agent 7	Control	/	Unkown
HY-171129	EP055		/	Unkown
HY-172772	Anti-PEDV agent 1	Inhibitor	/	Unkown
HY-173321	PAD4-IN-5	Inhibitor	/	Unkown
HY-17404S	Cilnidipine-d7	Inhibitor	/	Unkown
HY-175675	P2Y1 antagonist 4		/	Unkown
HY-176021	U-44069 serinol amide		/	Unkown
HY-176041	Troponin modulator 1		/	Unkown
HY-177091	AS2795440	Inhibitor	/	Unkown
HY-177296	GPR40 agonist 8	Agonist	/	Unkown
HY-178144	FPR2 agonist 5		/	Unkown
HY-178251S	L-Phenylalanine-d		/	Unkown
HY-178437	Bastadins-5		/	Unkown
HY-178963	Nav1.2-IN-2	Inhibitor	99.82%	Unkown
HY-179016	Ferroptosis/apoptosis inducer-3		/	Unkown
HY-179387	CXCR2-IN-3		/	Unkown
HY-180165	Antiallergic agent-5	Inhibitor	/	Unkown
HY-180244	P2L-003		/	Unkown
HY-18051	CXL 017		/	Unkown
HY-180891	Multitarget AD-IN-4	Inhibitor	/	Unkown
HY-181087	Anticancer agent 296		/	Unkown
HY-181755	Phenylaminojuglone AJ-2	Inhibitor	/	Unkown
HY-182068	NFI23	Inhibitor	/	Unkown
HY-182252	SAR296968	Inhibitor	/	Unkown
HY-182472	AL-38022A	Agonist	/	Unkown
HY-182551	SR-12062	Agonist	/	Unkown
HY-182736	YM-344484		/	Unkown
HY-183206	UR 8225		/	Unkown
HY-183549	Ferroptosis/apoptosis inducer-4	Inducer	/	Unkown
HY-183760	AChE/BChE-IN-37	Inhibitor	/	Unkown
HY-184034	Parethoxycaine	Inhibitor	/	Unkown
HY-184490	BPR1M492	Agonist	/	Unkown
HY-184937	COX-2/CA II-1	Inhibitor	/	Unkown
HY-184938	COX-2/CA II-2	Inhibitor	/	Unkown
HY-186165	KARI 101		/	Unkown
HY-186172	KS0365	Activator	/	Unkown
HY-19025	CV-159	Antagonist	/	Unkown
HY-19044	SKF 95601		/	Unkown
HY-19409	AJG049	Antagonist	/	Unkown
HY-204388	TAK-137	Agonist	/	Unkown
HY-34740S1	Ethylmalonic acid-d5	Inhibitor	98.09%	Unkown
HY-A0057AS2	Gabapentin-d4 hydrochloride	Inhibitor	/	Unkown
HY-B0006CS	(R)-Carvedilol-d4	Inhibitor	/	Unkown
HY-B0358AS	Flunarizine-d8 dihydrochloride		/	Unkown
HY-B0380S1	Trimebutine-d5 fumarate		/	Unkown
HY-B0380S2	Trimebutine-d3 hydrochloride		/	Unkown
HY-B0549S	Flavoxate-d5		/	Unkown
HY-B0596S	Taltirelin-13C,d3		/	Unkown
HY-B1221S	Flufenamic acid-d4		/	Unkown
HY-B1726	Phenacaine	Inhibitor	99.68%	Unkown
HY-B1837AR	β-Cyfluthrin (Standard)	Inhibitor	/	Unkown
HY-D0121	INDO 1		/	Unkown
HY-D0121B	INDO 1 pentasodium		/	Unkown
HY-D0157	ZnAF-2		/	Unkown
HY-D1424	Coelenterazine hcp		/	Unkown
HY-D1501	Fura PE-3 potassium		/	Unkown
HY-D1631A	Calcium green-5N hexapotassium		/	Unkown
HY-D1636	5-Nitro BAPTA		/	Unkown
HY-D1640	5',5-Difluoro BAPTA tetrapotassium		/	Unkown
HY-D1643	5,5'-Dinitro BAPTA AM		/	Unkown
HY-D1700	Mag-indo-1/AM		/	Unkown
HY-D1702	Mag-Fura-2 tetrapotassium		/	Unkown
HY-D1755	Fluo-3FF AM		/	Unkown
HY-D2952	BOCA-1-BG		/	Unkown
HY-D3030	Concanavalin A-FITC		/	Unkown
HY-D3031	Concanavalin A-TRITC		/	Unkown
HY-DY1055	TSQ (solution)		/	Unkown
HY-E70197	Calpain-1 (pig)		/	Unkown
HY-E70813	CAMKK2 Recombinant Human Active Protein Kinase		/	Unkown
HY-E70856	PKCθ Recombinant Human Active Protein Kinase		/	Unkown
HY-E70949	Protein Kinase C,Rat		/	Unkown
HY-E71159	1,4-Lactonase		/	Unkown
HY-E71164	1,5-Anhydro-D-fructose dehydratase		/	Unkown
HY-E71168	1,6-α-D-Mannosidase		/	Unkown
HY-E71616	2'-Phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase		/	Unkown
HY-N0043R	Ginsenoside Rd (Standard)	Inhibitor	/	Unkown
HY-N0215S16	L-Phenylalanine-13C-1		/	Unkown
HY-N0219R	Bicuculline (Standard)	Antagonist	/	Unkown
HY-N0392R	Polygalasaponin F (Standard)	Inhibitor	/	Unkown
HY-N10512	Gangliotetraose		/	Unkown
HY-N11887	Linocinnamarin	Inhibitor	99.14%	Unkown
HY-N1228	Soyacerebroside I		/	Unkown
HY-N15735	Cimicifugic acid D	Inhibitor	/	Unkown
HY-N15737	Fukinolic acid	Inhibitor	/	Unkown
HY-N16525	Muramine		/	Unkown
HY-N17738	Acetyljujuboside B		/	Unkown
HY-N18114	rel-(E)-6,7-Transdihydroxyligustilide		/	Unkown
HY-N18121	Taxinine A		/	Unkown
HY-N18279	Bulbocapnine	Antagonist	/	Unkown
HY-N18431	Stellettamide A TFA	Inhibitor	/	Unkown
HY-N19827	Monodesmoside saponin C		/	Unkown
HY-N2359A	Chelerythrine hydroxide		/	Unkown
HY-N2359S	Chelerythrine-d6 chloride		/	Unkown
HY-N3729	(-)-Denudatin B	Inhibitor	97.88%	Unkown
HY-N6687A	Calcimycin hemicalcium salt		/	Unkown
HY-N6687B	Calcimycin hemimagnesium		/	Unkown
HY-N6687C	Calcimycin hemicalcium hemimagnesium		/	Unkown
HY-N7594	Senecionine acetate		/	Unkown
HY-NP164A	Concanavalin A-Cy5.5		/	Unkown
HY-NP164C	Concanavalin A-AF350		/	Unkown
HY-NP164D	Concanavalin A-AF405		/	Unkown
HY-NP164E	Concanavalin A-AF430		/	Unkown
HY-NP164H	Concanavalin A-AF532		/	Unkown
HY-NP164I	Concanavalin A-AF546		/	Unkown
HY-NP164J	Concanavalin A-AF555		/	Unkown
HY-NP164K	Concanavalin A-AF568		/	Unkown
HY-NP164M	Concanavalin A-AF680		/	Unkown
HY-NP164N	Concanavalin A-Cy3		/	Unkown
HY-NP164O	Concanavalin A-Cy5		/	Unkown
HY-P0033A	Argireline acetate	Inhibitor	/	Unkown
HY-P0221A	PACAP (1-38), human, ovine, rat TFA	Inducer	/	Unkown
HY-P10316	CaMKI(299-320)	Modulator	/	Unkown
HY-P10328	Vasoactive intestinal contractor	Inhibitor	/	Unkown
HY-P1075A	CALP3 TFA	Inhibitor	/	Unkown
HY-P1076	CALP2	Antagonist	/	Unkown
HY-P10773	CTP-amiodarone	Inhibitor	/	Unkown
HY-P10811	Na+-Ca2+ Exchanger	Inhibitor	/	Unkown
HY-P10972	GIP (22-51) human		/	Unkown
HY-P11019	IS4	Antagonist	/	Unkown
HY-P11082	APGW-amide		/	Unkown
HY-P11405	[D-Arg1,D-Trp5,7,9,Leu11]-Substance P	Antagonist	/	Unkown
HY-P11700	AAPDARETA		/	Unkown
HY-P11825	APH-IN-1	Inhibitor	/	Unkown
HY-P1247A	Calcineurin autoinhibitory peptide TFA	Inhibitor	/	Unkown
HY-P1250A	RFRP-3(human) TFA	Agonist	/	Unkown
HY-P1345	TLQP-21	Agonist	/	Unkown
HY-P1366A	des-Gln14-Ghrelin TFA		/	Unkown
HY-P1437A	Neuropeptide S (Mouse) TFA	Agonist	/	Unkown
HY-P1479	Calmodulin-Dependent Protein Kinase II (290-309)		/	Unkown
HY-P2424	Cholecystokinin-J		/	Unkown
HY-P2722	Bovine brain Calcineurin		/	Unkown
HY-P3168	Martentoxin	Inhibitor	/	Unkown
HY-P3187A	exo-β-1,4-xylosidase, Clostridium stercorarium		/	Unkown
HY-P3187B	exo-β-1,4-xylosidase, Bacteroides ovatus		/	Unkown
HY-P3316	OSK-1	Inhibitor	/	Unkown
HY-P3419A	PAMP-12 (unmodified) TFA	Agonist	/	Unkown
HY-P3811	Autocamtide-3		/	Unkown
HY-P3943	Calmodulin Dependent Protein Kinase Substrate Analog		/	Unkown
HY-P3944	Calmodulin Dependent Protein Kinase Substrate		/	Unkown
HY-P4368	Z-APF-CMK	Inhibitor	/	Unkown
HY-P5142	ω-Hexatoxin-Hv1a	Inhibitor	/	Unkown
HY-P5154	Tamapin	Antagonist	/	Unkown
HY-P5319	MCaE12A	Activator	/	Unkown
HY-P5422	Caloxin 3A1	Inhibitor	/	Unkown
HY-P5869	Kurtoxin		/	Unkown
HY-P5870	KTX-Sp2	Inhibitor	/	Unkown
HY-P6008	Myoregulin		/	Unkown
HY-P6008A	Myoregulin TFA		/	Unkown
HY-P6013	wt hMLN	Inhibitor	/	Unkown
HY-RS01768	CA2 Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS01909	Car2 Mouse Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS01910	Car2 Rat Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-U00026	Semotiadil recemate fumarate		/	Unkown
HY-W040028	Cartap hydrochloride	Inducer	/	Unkown
HY-W069974	Ca2+ -Langerin-IN-1		/	Unkown
HY-W127795	Fluo-3 ammonium		/	Unkown
HY-W250153A	Adenosine 3'-phosphate 5'-phosphosulfate lithium, hydrate	Antagonist	/	Unkown
HY-W339833	1-Myristoyl-2-hydroxy-sn-glycero-3-phosphate sodium		/	Unkown
HY-W403046A	D-myo-Inositol-4-phosphate monoammonium	Activator	/	Unkown
HY-W707161	4-Methyl-2-(1-piperidinyl)-quinoline-d10		/	Unkown
HY-W710915	Aprindine hydrochloride-d10		/	Unkown
HY-W711474	(-)-Menthol-d4		/	Unkown
HY-W721517	Gabapentin-d10		/	Unkown
HY-W751362	Cetiedil	Inhibitor	/	Unkown
HY-W783254	C18 LPA		/	Unkown
HY-W795960	D-myo-Inositol 1,4,5-trisphosphate sodium salt		/	Unkown
HY-W838171	Tiaramide		/	Unkown
HY-Z8176	(Z)-Flunarizine	Inhibitor	/	Unkown
HY-101360R	1-EBIO (Standard)	Agonist	/	Unkown
HY-101669	TDN345	Antagonist	/	Unkown
HY-101685	Iganidipine	Antagonist	/	Unkown
HY-10341D	Fasudil mesylate		/	Unkown
HY-108984	BBMP		/	Unkown
HY-110091	TRPV1 antagonist 9	Antagonist	/	Unkown
HY-113723	MRS2298	Antagonist	/	Unkown
HY-115231	ci-IP3/PM		/	Unkown
HY-115767S	(±)-1,2-Diolein-13C3	Activator	/	Unkown
HY-116072	Antiarrhythmic agent-2	Inhibitor	/	Unkown
HY-116723	CFMMC	Antagonist	/	Unkown
HY-117055	Ro 18-3981	Inhibitor	/	Unkown
HY-117982	SKI2496		/	Unkown
HY-119884	DC-120		/	Unkown
HY-121186S	Bevantolol-d7 hydrochloride	Antagonist	/	Unkown
HY-121253	NAADP receptor modulator-1	Inhibitor	/	Unkown
HY-121366	Kadethrin	Inhibitor	/	Unkown
HY-121720	L 657925	Antagonist	/	Unkown
HY-121914	(2-Chlorophenyl)diphenylmethanol	Inhibitor	99.92%	Unkown
HY-126072	(Rac)-GK563		/	Unkown
HY-126821B	Fluo-3 sodium		/	Unkown
HY-130358	PDDHV	Activator	/	Unkown
HY-131764	2'-O-MB-cGMP sodium	Inhibitor	/	Unkown
HY-133614	Dihydroisopimaric acid	Activator	/	Unkown
HY-134368	Ap3A	Inhibitor	/	Unkown
HY-135110A	Rp-8-Br-cGMPS		/	Unkown
HY-135478A	LY393615 free base	Inhibitor	/	Unkown
HY-13551C	Amsacrine isethionate		/	Unkown
HY-13551D	Amsacrine lactate		/	Unkown
HY-135556A	Norfluoxetine oxalate		/	Unkown
HY-137162	Dotarizine	Inhibitor	/	Unkown
HY-138035	Tenellin		/	Unkown
HY-141613A	Dioleyl phosphatidylserine	Activator	/	Unkown
HY-145536	α-D-Glucose-1-phosphate disodium tetrahydrate		98.0%	Unkown
HY-14656S2	Diltiazem-d6 hydrochloride	Antagonist	/	Unkown
HY-149779	RyR2 stabilizer-1	Modulator	/	Unkown
HY-152051S	Mabuterol-d9 hydrochloride	Agonist	/	Unkown
HY-164090	Adenosine 3'-phosphate 5'-phosphosulfate	Antagonist	/	Unkown
HY-164631	EL20	Inhibitor	/	Unkown
HY-167203	AJG049 free base	Antagonist	/	Unkown
HY-168377	Fluo-4 potassium		/	Unkown
HY-168382	5R(6S)-EET	Agonist	/	Unkown
HY-168382A	5S(6R)-EET	Agonist	/	Unkown
HY-16935S	Mavatrep-d6	Antagonist	/	Unkown
HY-169780	(S)-AMG-628	Antagonist	/	Unkown
HY-171469	SKP-451	Agonist	/	Unkown
HY-172321	Etheno-NAADP sodium		/	Unkown
HY-17404S1	Cilnidipine-d4	Inhibitor	/	Unkown
HY-174829	7,4'-Dimethoxy-3-hydroxyflavone		/	Unkown
HY-183907	Cicletanine	Inhibitor	/	Unkown
HY-50722B	NNC 55-0396 free base	Inhibitor	/	Unkown
HY-A0082S	Diphenidol-d10 hydrochloride	Antagonist	/	Unkown
HY-B0493S	Niflumic Acid-d5	Inhibitor	/	Unkown
HY-B0549AS	Flavoxate-d4 hydrochloride		/	Unkown
HY-B0632B	(2R,3R)-Diltiazem hydrochloride	Inhibitor	/	Unkown
HY-B0632S2	Diltiazem-d4	Inhibitor	/	Unkown
HY-D0110B	Fura-2 pentasodium		/	Unkown
HY-D1608	BODIPY FL Thapsigargin	Inhibitor	/	Unkown
HY-N0081A	(-)-Praeruptorin A	Inhibitor	/	Unkown
HY-N0724R	Mesaconitine (Standard)	Activator	/	Unkown
HY-N10754	Aschantin	Inhibitor	/	Unkown
HY-N13916	Alternaric acid		/	Unkown
HY-N5123	α-L-Rhamnose		/	Unkown
HY-N7063S	Nerol-d2		/	Unkown
HY-N7063S1	Nerol-d6		/	Unkown
HY-N9422	Adenosine 3'-phosphate 5'-phosphosulfate triethylamine	Antagonist	/	Unkown
HY-N9554	WIN-64821	Antagonist	/	Unkown
HY-P2209	Nummularine B	Inhibitor	/	Unkown
HY-W002006	6-Amino-1,3-dimethyluracil		/	Unkown
HY-W1113135A	Carboxymethyl-β-cyclodextrin sodium salt, for capillary electrophoresis		/	Unkown
HY-W150752	Triphenylethylene		99.86%	Unkown
HY-W166106	Bromoriluzole	Inhibitor	/	Unkown
HY-W250153	Adenosine 3'-phosphate 5'-phosphosulfate lithium	Antagonist	/	Unkown
HY-W288025	ALXR-agonist-6	Agonist	/	Unkown
HY-W755295	Mabuterol hydrochloride	Agonist	/	Unkown
HY-W778574	BAPTA tetracesium	Inhibitor	/	Unkown
HY-W931056	AMG-628	Inhibitor	/	Unkown
HY-U00354	CP-060	Antagonist	/	Unkown

Inhibitory Antibodies (1)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-P992349	DXL625		/	Unkown

Orthologs Information

Species	Symbol	Source	ID
Canis familiaris	CA2	VGNC	VGNC:38610
Rattus norvegicus	CA2	RGD	RGD:2240
Felis catus	CA2	VGNC	VGNC:60250
Mus musculus	CA2	MGD	MGI:88269
Macaca mulatta	CA2	VGNC	VGNC:70490
Others	CA2	NCBI